Skip to Content

'
Brian R. Weston, MD, FASGE

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Gastroenterology, Hepat,& Nutr, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Unit Number: 1466
Houston, TX 77030
Phone: 713-794-5073

Education & Training

Degree-Granting Education

1999 Royal College of Surgeons Ireland, Dublin, Ireland, MD, Medical School
1992 Tufts University, Medford, MA, BS, Undergraduate

Postgraduate Training

8/2007-7/2008 Clinical Fellowship / Clinical Instructor, Therapeutic Endoscopy, The University of Texas M. D. Anderson Cancer Center, Houston, TX
7/2004-6/2007 Clinical Fellowship, Gastroenterology, The University of Texas Health Science Center - M. D. Anderson Cancer Center, Houston, TX
7/2003-6/2004 Clinical Fellowship, Transplant Hepatology, Indiana University School of Medicine, Indianapolis, IN
7/2000-6/2003 Clinical Residency, Internal Medicine, Indiana University School of Medicine, Indianapolis, IN
7/1999-6/2000 Clinical Internship, Medicine and Surgery, Royal College of Surgeons - Beaumont Hospital, Dublin, Ireland

Board Certifications

8/2004 Recertified: American Board of Internal Medicine - Internal Medicine, Recertification Date: 10/2013
2/2009 Medical Council Ireland - Specialist Registration Gastroenterology
11/2008 American Board of Internal Medicine - Transplant Hepatology
10/2007 American Board of Internal Medicine - Gastroenterology
8/2004 American Board of Internal Medicine - Internal Medicine

Experience/Service

Academic Appointments

Assistant Professor, Gastroenterology, Division of Internal Medicine, The University of Washington School of Medicine, Seattle, WA, 2009-2010

Professional Memberships

American College of Gastroenterology, Bethesda, MD
Member, 2007
American Gastroenterology Association, Bethesda, MD
Member, 2007
American Medical Association, Chicago, IL
Member, 2000
American Society for the Study of Liver Diseases, Alexandria, VA
Member, 2008
American Society of Gastrointestinal Endoscopy, Oak Brook, IL
Member, 2007
European Society of Gastrointestinal Endoscopy, Munich, Germany
Member, 2011
Texas Medical Association / Harris County Medical Society, Houston, TX
Member, 2012

Selected Publications

Peer-Reviewed Original Research Articles

1. Sudo K, Wang X, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Rice DC, Lee JH, Weston B, Bhutani MS, Hiremath A, Charalampakis N, Komaki R, Blum MA, Swisher SG, Maru DM, Skinner HD, Garris JL, Rogers JE, Hofstetter WL, Ajani JA. A nomogram to predict distant metastases after multimodality therapy of patients with localized esophageal cancer. JNCCN. In Press.
2. Sudo K, Wang x, Xiao L, Wadhwa R, Shiozaki H, Elimova , Rice DC, Lee JH, Weston B, Bhutani MS, Hiremath A, Charalampakis N, Komaki R, Blum MA, Swisher SG, Maru DM, Skinner HD, Garris JL, Rogers JE, Hofstetter WL, Ajani JA. A nomogram to Predict distant Metastases after multimodality therapy for patients with localized esophageal cancer. J Natl Compr Canc Netw 14(2):173-9, 2/2016.
3. Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani M, Shafi M, Weston B, Pande M, Bresalier R, Rashid A, Mishra L, Davila M, Stroehlein J. Outcomes of Endoscopic Mucosal Resection as An Alternative to Surgery in Patients with Complex Colon Polyps. Gastrointest Endosc. e-Pub 2/2016.
4. Charalampakis N, Xiao L, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Planjery V, Rogers JE, Matamoros A Jr, Sagebiel T, Das P, Lee JH, Bhutani MS, Weston B, Estrella JS, Badgwell BD, Ajani JA. Initial standardized uptake value of position emission tomography influences the prognosis of patients with localized gastric adenocarcinoma treated preoperatively. Oncology. e-Pub 9/2015.
5. Elimova E, Wang X, Etchebehere E, Shiozaki H, Shimodaira Y, Wadhwa R, Planjery V, Charalampakis N, Blum MA, Hofstetter W, Lee JH, Weston BR, Bhutani MS, Rogers JE, Maru D, Skinner HD, Macapinlac HA, Ajani JA. 18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients. Eur J Cancer. e-Pub 8/2015.
6. Dhupar R, Rice RD, Correa AM, Weston BR, Bhutani MS, Maru DM, Betancourt SL, Rice DC, Swisher SG, Hofstetter WL. Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal use of Endoscopic Resection. Ann Thorac Surg. e-Pub 7/2015.
7. Bektas M, Krishna SG, Ross WA, Weston B, Katz MH, Fleming JB, Lee JH, Bhutani MS. Prevalence of extra-pancreatic cysts in patients with cystic pancreatic lesions detected by endoscopic ultrasound. Endosc Ultrasound 3(219-24), 7/2015.
8. Raju GS, Lum PJ, Slack R, Thirumurthi SI, Lynch PM, Miller E, Weston BR, Davila ML, Bhutani MS, Shafi MA, Bresalier RS, Dekovich AA, Lee JH, Guha S, Pande M, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR, Ross WA. Natural Language Processing As an Alternative to Manual Reporting of Colonoscopy Quality Metrics. Gastrointest Endosc. e-Pub 4/2015.
9. Neishaboori N, Wadhwa R, Nogueras-Gonzalez G, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee J, Bhutani M, Weston B, Blum M, Rogers J, Garris J, Rice D, Komaki R, Swisher S, Skinner H, Hofstetter W, Ajani J. Distribution of resistant esophageal adenocarcinoma in the resected specimens of clinical stage III patients after chemoradiation: Its Clinical Implications. Oncology 89(2):65-9, 3/2015.
10. Shiozaki H, Slack R, Sudo K, Elimova E, Wadhwa R, Chen H, Maru D, Komaki R, Lee JH, Weston BR, Bhutani M, Blum M, Skinner HD, Hofstetter W, Ajani J. Geographic distribution of regional metastatic nodes affects outcome of tri-modality-eligible patients with esophageal adenocarcinoma. Oncology 88(6):332-6, 2/2015.
11. Shiozaki H, Slack R, Sudo K, Elimova E, Wadhwa R, Chen HC, Skinner HD, Komaki R, Lee JH, Weston B, Bhutani MS, Blum MA, Rogers JE, Maru DM, Hofstetter WL, Ajani JA. Geographic Distribution of Regional Metastatic Nodes Affects the Outcome of Trimodality-Eligible Patients with Esophageal Adenocarcinoma. Oncology. e-Pub 2/2015.
12. Neishaboori N, Wadhwa R, Nogueras-González GM, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee JH, Bhutani MS, Weston B, Blum MA, Rogers JE, Garris JL, Rice DC, Komaki R, Swisher SG, Skinner HD, Hofstetter WL, Ajani JA. Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications. Oncology 89(2):65-9, 2015. e-Pub 3/2015.
13. Shiozaki H, Slack R, Sudo K, Elimova E, Wadhwa R, Chen HC, Skinner HD, Komaki R, Lee JH, Weston B, Bhutani MS, Blum MA, Rogers JE, Maru DM, Hofstetter WL, Ajani JA. Geographic distribution of regional metastatic nodes affects the outcome of trimodality-eligible patients with esophageal adenocarcinoma. Oncology 88(6):332-6, 2015. e-Pub 2/2015.
14. Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova EE, Song S, Ye Y, Huang M, Ajani J, Wu X. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer 120(23):3635-41, 12/2014. e-Pub 8/2014.
15. Sudo K, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Taketa T, Blum MA, Lee JH, Bhutani MS, Weston B, Ross WA, Komaki R, Rice DC, Swisher SG, Hofstetter WL, Maru DM, Skinner HD, Ajani JA. Importance of surveillance and success of salvage Strategies after definitive chemoradiation in patients with esophageal cancer. J Clin Oncol 32(30):3400-5, 10/2014. e-Pub 9/2014.
16. Taketa T, Sudo K, Correa AM, Wadhwa R, Shiozaki H, Elimova E. Campagna MC, Blum MA, Skinner HD, Komaki RU, Lee JH, Bhutani MS, Weston BR, Rice DC, Swisher SG, Maru DM, Hofstetter WL, Ajani JA. Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma. J Natl Compr Canc Netw 12(8):1139-44, 8/2014.
17. Shiozaki H, Sudo K, Xiao L, Wadhwa R, Elimova E, Hofstetter WL, Skinner HD, Lee JH, Weston B, Bhutani MS, Blum MA, Maru DM, Ajani JA. Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer. Oncology 7(86(5-6)):336-339, 6/2014.
18. Song S, Ajani JA, Honjo S, Maru DM, Chen Q, Scott AW, Heallen TR, Xiao L, Hofstetter WL, Weston B, Lee JH, Wadhwa R, Sudo K, Stroehlein JR, Martin JF, Hung MC, Johnson RL. Hippo coactivator YAP1 upregulates SOX9 and endows stem-like properties to esophageal cancer cells. Cancer Res. e-Pub 6/2014.
19. Ajani JA, Wang X, Song S, Suzuki A, Taketa T, Sudo K, Wadhwa R, Hofstetter WL, Komaki R, Maru DM, Lee JH, Bhutani MS, Weston B, Baladandayuthapani V, Yao Y, Honjo S, Scott AW, Skinner HD, Johnson RL, Berry D. ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. Mol Oncol 8(1):142-9, 2/2014. e-Pub 10/2013. PMCID: PMC3946849.
20. Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Skinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Locoregional Failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies. J Clin Oncol 31(34):4306-10, 12/2013. e-Pub 10/2013. PMCID: PMC3837091.
21. Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmus J, Swisher SG, Hofstetter WL, Ajani JA. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation. Ann Oncol 24(11):2854-9, 11/2013.
22. Wadhwa R, Taketa T, Correa AM, Sudo K, Campagna MC, Blum MA, Komaki R, Skinner H, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: Implications for screening and surveillance. Oncology 85(4):204-7, 9/2013.
23. Taketa T, Xiao L, Sudo K, Suzuki A, Wadhwa R, Blum MA, Lee JH, Weston B, Bhutani MS, Skinner H, Komaki R, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Propensity-based matching between esophagogastric cancer patients who had surgery and who declined surgery after preoperative chemoradiation. Oncology 85(2):95-9, 7/2013.
24. Suzuki R, Lee JH, Krishna SG, Ramireddy S, Qiao W, Weston B, Ross WA, Bhutani MS. Repeat endoscopic ultrasound-guided fine needle aspiration for solid pancreatic lesions at a tertiary referral center will alter the initial inconclusive result. J Gastrointestin Liver Dis 22(2):183-7, 6/2013.
25. Weston BR, Bhutani MS. Technical Review: Optimizing diagnostic yield for EUS-guided sampling of solid pancreatic lesions. Gastroenterology and Hepatology 9(6):35-63, 6/2013. PMCID: PMC3736792.
26. Krishna SG, Bhutani MS, Mosher CH, Staerkel GA, Weston BR. A first report of endoscopic ultrasound for the diagnosis of pancreatic amyloid deposition in immunoglobulin light chain (a1) amyloidosis (primary amyloidosis). JOP 14(3):283-5, 5/2013.
27. Chen WC, Weston BR, Krishna SG, Gomez G, Rashid A, Katz MH, Lee JE, Raju GS. Prolonged Endoloop ligation for removal of gastrointestinal tumors. Endoscopy 45(S(02)):E69-70, 3/2013.
28. Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer. Eur J Cancer 48(18):3396-404, 12/2012. PMCID: PMC3869451.
29. Suzuki A, Xiao L, Taketa T, Blum MA, Matamoros A Jr, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA. Localized gastric cancer treated with chemoradiation without surgery: UT MD Anderson Cancer Center experience. Oncology 82(6):347-51, 10/2012.
30. Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery After Preoperative Chemoradiation. Oncology. 83(5):300-4, 9/2012. PMCID: PMC3832345.
31. Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, Ajani JA. Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. Oncology 82(2):108-13, 2/2012.
32. Weston BR. Mediastinal paraganglioma: EUS findings and a cautious reminder of potential risks from FNA of unknown mediastinal masses. Visible Human Journal of Endoscopy 11(2), 2012.
33. Weston BR, Ross WA, Liu J, Lee JH. Clinical outcomes of nitinol and stainless steel uncovered metal stents for malignant biliary strictures: is there a difference? Gastrointestinal Endoscopy 72(6):1195-200, 12/2010. PMID: 21111871.
34. Weston BR, Iyer RB, Qiao W, Lee JH, Bresalier RS, Ross WA. Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer 116(6):1454-61, 3/2010. PMID: 20143447.
35. Weston BR, Thosani N, Bektas M, Oruc N, Bhutani MS. Pill esophagitis masquerading as esophageal cancer on endoscopy and endoscopic ultrasound. Visible Human Journal of Endoscopy 2010;9(2) 9(2), www.vhjoe.org, 2010.
36. Weston BR, Bhutani MS. Metastatic recurrent appendiceal adenocarcinoma to the peritoneum diagnosed by rectal endoscopic ultrasound. Visible Human Journal of Endoscopy 8(1), www.vhjoe.com, 2009.
37. Weston BR, Ross WA, Wolff RA, Evans D, Lee JE, Wang X, Xiao LC, Lee JH. Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopancreatography? Cancer 112(11):2417-23, 6/2008. PMID: 18404695.
38. Weston BR, Anandasabapathy S, Bhutani MS. Splenule masquerading as pancreatic neuroendocrine tumor. Visible Human Journal of Endoscopy 7(2), www.vhjoe.com, 2008.
39. Weston BR, Chadalawada V, Chalasani N, Kwo P, Overley CA, Symms M, Strahl E, Rex DK. Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients. American Journal of Gastroenterology 98(11):2440-7, 11/2003. PMID: 14638346.
40. Weston BR, Helper DJ, Rex DK. Positive predictive value of endoscopic features deemed typical of gastric fundic gland polyps. J Clin Gastroenterol 36(5):399-402, 5/2003. PMID: 12702980.

Book Chapters

1. Bhutani MS, Weston BR, Kongkam P. Colorectal Endoscopic Ultrasound. In: Endoscopic Ultrasonography, 3. Ed(s) Gress F, Savides T. John Wiley and Sons Ltd: Oxford, UK. In Press.
2. Weston BR, Ko C. Biliary tract disease in pregnancy. In: Complications of Pregnancy, 6th. Ed(s) Cohen WR, August P. PMPH-USA Ltd. Shelton, CT, 2013.
3. Weston BR, Bhutani MS. Endoscopic Ultrasound (EUS) in Inflammatory Bowel Disease (IBD). In: EUS Pathology with Digital Anatomy Correlation. Ed(s) Bhutani MS, Deutch JC. People's Medical Publishing House: Shelton, Connecticut, 397-400, 2010.
4. Weston BR, Bhutani MS. Ovarian and Gynecological Lesions. In: EUS Pathology with Digital Anatomy Correlation. Ed(s) Bhutani MS, Deutch JC. People's Medical Publishing House: Shelton, Connecticut, 369-374, 2010.

Manuals, Teaching Aids, Other Teaching Publications

1. Weston BR. CME-Are clips useful in the prevention of delayed bleeding after endoscopic mucosal resection?. 77, 3. Ed(s) Buxbaum J, Ross W, Tang SH, Raju GS, Eisen GM. Gastrointest Endosc, 491.e2-491.e4, 3/2013.
2. Weston BR. CME-Is there a difference in adenoma recurrence by race-ethnicity?. 77, 3. Ed(s) Buxbaum J, Ross W, Tang SJ, Raju GS, Eisen GM. Gastrointest Endosc, 491.e2; 491 e.4-5, 3/2013.
3. Weston BR. CME-Management for patients with tubular adenoma. 77, 3. Ed(s) Buxbaum J, Ross W, Tang SJ, Raju GS, Eisen GM. Gastrointest Endosc, 491.e1; 491.e3, 3/2013.
4. Weston BR. CME-Surveillance colonoscopy in patients with a serrated polyp. 77, 3. Ed(s) Buxbaum J, Ross W, Tang SJ, Weston B, Raju GS, Eisen GM. Gastrointest Endosc, 491.e1; 491.e3-4, 3/2013.

Last updated: 6/17/2016